ARDX
Price:
$5.6
Market Cap:
$1.32B
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]
Industry
Biotechnology
IPO Date
2014-06-19
Stock Exchange
NASDAQ
Ticker
ARDX
According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.21. This represents a change of -12.11% compared to the average of 4.79 of the last 4 quarters.
The mean historical Current Ratio of Ardelyx, Inc. over the last ten years is 9.11. The current 4.21 Current Ratio has changed 4.52% with respect to the historical average. Over the past ten years (40 quarters), ARDX's Current Ratio was at its highest in in the June 2015 quarter at 25.95. The Current Ratio was at its lowest in in the December 2022 quarter at 2.07.
Average
9.11
Median
9.21
Minimum
2.07
Maximum
20.03
Discovering the peaks and valleys of Ardelyx, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 720.40%
Maximum Annual Current Ratio = 20.03
Minimum Annual Increase = -65.91%
Minimum Annual Current Ratio = 2.07
Year | Current Ratio | Change |
---|---|---|
2023 | 4.88 | 135.93% |
2022 | 2.07 | -11.63% |
2021 | 2.34 | -65.91% |
2020 | 6.87 | -39.51% |
2019 | 11.36 | 13.30% |
2018 | 10.02 | 19.54% |
2017 | 8.39 | -21.06% |
2016 | 10.62 | -26.90% |
2015 | 14.53 | -27.43% |
2014 | 20.03 | 720.40% |
The current Current Ratio of Ardelyx, Inc. (ARDX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.10
5-year avg
5.51
10-year avg
9.11
Ardelyx, Inc.’s Current Ratio is greater than BioLineRx Ltd. (1.61), less than Lexicon Pharmaceuticals, Inc. (11.51), greater than Seres Therapeutics, Inc. (1.38), greater than ImmunityBio, Inc. (3.91), less than Zura Bio Limited (0), less than Hepion Pharmaceuticals, Inc. (12.57), less than AVROBIO, Inc. (5.62), less than Verastem, Inc. (26.17), greater than Mereo BioPharma Group plc (3.28), less than Terns Pharmaceuticals, Inc. (6.07), less than PDS Biotechnology Corporation (21.02), greater than Inozyme Pharma, Inc. (3.84), less than HOOKIPA Pharma Inc. (9.84), greater than null (3.86),
Company | Current Ratio | Market cap |
---|---|---|
1.61 | $55.61M | |
11.51 | $582.00M | |
1.38 | $145.36M | |
3.91 | $2.35B | |
0 | $230.86M | |
12.57 | $4.20M | |
5.62 | $5.24M | |
26.17 | $96.58M | |
3.28 | $664.26M | |
6.07 | $549.60M | |
21.02 | $107.88M | |
3.84 | $312.42M | |
9.84 | $159.50M | |
3.86 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ardelyx, Inc.'s Current Ratio?
How is the Current Ratio calculated for Ardelyx, Inc. (ARDX)?
What is the highest Current Ratio for Ardelyx, Inc. (ARDX)?
What is the 3-year average Current Ratio for Ardelyx, Inc. (ARDX)?
What is the 5-year average Current Ratio for Ardelyx, Inc. (ARDX)?
How does the current Current Ratio for Ardelyx, Inc. (ARDX) compare to its historical average?